Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Intangibles (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Intangibles came in at $4.2 billion in Q2 2026, down 17.2% year-over-year from $5.0 billion in Q2 2025, and down 5.11% quarter-over-quarter from $4.4 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Intangibles (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Intangibles across 18 years of filings, most recently posting $4.2 billion for Q2 2026.

  • In Q2 2026, Intangibles fell 17.2% year-over-year to $4.2 billion; the TTM figure through Jun 2026 stood at $4.2 billion (down 17.2% YoY), while the FY2025 annual figure was $4.6 billion, down 16.36% from the prior year.
  • Intangibles came in at $4.2 billion for Q2 2026 at Bausch Health Companies, down from $4.4 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $6.7 billion in Q3 2023 to a low of $4.2 billion in Q2 2026.
  • Average Intangibles over 5 years is $5.6 billion, with a median of $5.6 billion recorded in 2023.
  • Year-over-year, Intangibles climbed 11.69% in 2023 and declined 17.2% in 2026.
  • Over 5 years, Intangibles stood at $5.8 billion in 2022, then increased by 11.31% to $6.5 billion in 2023, then fell by 14.02% to $5.6 billion in 2024, then decreased by 16.36% to $4.6 billion in 2025, then dropped by 9.99% to $4.2 billion in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $4.2 billion in Q2 2026, $4.4 billion in Q1 2026, and $4.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 3.45 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 13.68 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 1.09 Bn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 587.83 Mn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 4.18 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 142.48 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 449.86 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 29.23 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn -
10 RedHill Biopharma 171.02 Mn 171.02 Mn - 5.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.18 Bn
Mar 31, 2026 4.40 Bn
Dec 31, 2025 4.64 Bn
Sep 30, 2025 4.83 Bn
Jun 30, 2025 5.05 Bn
Mar 31, 2025 5.30 Bn
Dec 31, 2024 5.55 Bn
Sep 30, 2024 5.65 Bn
Jun 30, 2024 5.90 Bn
Mar 31, 2024 6.18 Bn
Dec 31, 2023 6.46 Bn
Sep 30, 2023 6.73 Bn
Jun 30, 2023 5.30 Bn
Mar 31, 2023 5.55 Bn
Dec 31, 2022 5.80 Bn
Sep 30, 2022 6.02 Bn
Jun 30, 2022 6.32 Bn
Mar 31, 2022 6.63 Bn
Dec 31, 2021 6.95 Bn
Sep 30, 2021 7.26 Bn